Search

9 Feb 2022: Single-source precursors for multiple-function coatings Case Ref: Gre-7694-20. Dr Tim RosserCommercialisation Associatetim.rosser@enterprise.cam.ac.uk.

7 Jul 2024: Page 2/5 Reference number: GRE-7381-20. Reduced number of erythroblasts (Figure B). ... Powered by TCPDF (www.tcpdf.org). Page 5/5 Reference number: GRE-7381-20.

14 Jul 2021: Case Ref: Pen-7846-20. Dr Gillian DavisCommercialisation Directorgillian.davis@enterprise.cam.ac.uk. Richard Penty is Professor of Photonics in the Department of Engineering at the University of Cambridge.

7 Jul 2024: Page 2/4 Reference number: BON-7603-20. and blood oxygen levels (pulse oximetry). ... Powered by TCPDF (www.tcpdf.org). Page 4/4 Reference number: BON-7603-20.

9 Mar 2022: Reliable redox flow battery state-of-charge measurement. A low cost, in line technique to maintain optimal performance Case Ref: Gre-7712-20.

7 Jul 2024: Page 1/4 Reference number: XIA-7922-20. A CHALLENGE IN RETROFITTING AGING HOUSING STOCK IS SUPPLY-SIDE SHORTAGE IN DESIGN & CONSTRUCTION. ... Page 2/4 Reference number: XIA-7922-20. Informed by these estimates, homeowners can make key decisions

7 Jul 2024: Page 1/3 Reference number: MAL-7401-20. and safety problems to deliver drugs to hard-to-reach brain tumours. ... Powered by TCPDF (www.tcpdf.org). Page 3/3 Reference number: MAL-7401-20.

7 Jul 2024: Page 1/2 Reference number: GRE-7694-20. Benefits. Improved lifetime of NMC cathodes without compromising capacity of Li-ion batteries. ... Powered by TCPDF (www.tcpdf.org). Page 2/2 Reference number: GRE-7694-20.

7 Jul 2024: Page 2/8 Reference number: DE-7580-20. α-LGR5 Bispecific T cell Engagers (BiTEs). ... α-LGR5 BiTE activates T cells leading to efficienttumour cell destruction. Page 3/8 Reference number: DE-7580-20.

4 Mar 2020: In 1995, Molecular Simulations was acquired by Accelrys Inc., which handled sales of CASTEP for almost 20 years. ... 20 Cambridge Enterprise Annual Review 2019. 2018-19 £’000. 2017-18£’000. Income generated by Cambridge Enterprise operations 11,003

7 Jul 2024: Have been successfully fabricated and demonstrated. Patents. PCT Application EP2022/076077 (priority date 20 September 2021).

7 Jul 2024: Benefits. Technology is the first specific treatment for BKPyV-associated diseases(e.g. PVAN and HC) in immunosuppressed patients, holding the potentialto benefit around 20,000 affected transplant recipients annually. ... criticalhost factor for BK

20 Jun 2021: National application 3. National application 2. National application 1. Monopoly for 20 years from priority filing.

7 Jul 2024: Release of β-lapachone from peptide prodrug. Release of β-lapachone 1 from peptide prodrug 26 at 254 nm after in vitro dipeptide cleavage byprotease cathepsin B (MES 20 mM buffer,

26 Mar 2024: 18 NuQuantum: pioneering Quantum Networking for transformative computing. 20 Establishing a home-grown, inclusive innovation roadmap to prosperity for Greater Cambridge. ... 06 OCTOBER. 20 MARCH. £29.8bn economic impact of the University of Cambridge

7 Jul 2024: Fibers are washable (AAATCC standard) with Iph,wash/Iph,nowash 94%and72% at 20 and 30 cycles.

7 Jul 2024: Low barrier to entry agritech market. Each year, between 20-40% of crops are expected to be lost worldwide todisease.

29 May 2019: display contractile ability in response to carbachol treatment. There was a 10-20% change of surface area in contracting cells.

7 Jul 2015: 0 months. Monopoly for 20 years from filing. 6 months 12 months 18 months 24 months 30 months 5 years.

28 Apr 2020: 2009, 90,1202. J Virol. 2010, 84(20), 10937. 2. Herpes Simplex Virus Type 1 and 2 (HSV-1 and -2) antibodies.

12 Mar 2021: £2bn. 4 Cambridge Enterprise Annual Review 2020. Some 20,000 people in Botswana are hearing impaired. ... 2019–20 £’000. 2018–19£’000. Investment in IP assets (patent and proof of concept) (1,075) (803).

4 Jan 2016: 20), taking viewers beyond the licences, patents and investments we oversee to illuminate the real-world impact of the research we support. ... Total expenditure (30,146) (18,880). Net income/(expenditure) for the year (156) (20).

8 May 2015: A recent UK review suggested that these stakes range from 20-67% in the UK and 5-100% in the US.

8 May 2015: A recent UK review suggested that these stakes range from 20-67% in the UK and 5-100% in the US.

6 Mar 2017: Dr Mahadeva, Consultant Respiratory Physician at Addenbrooke’s Hospital (Director of Cambridge Antitrypsin Centre), Associate Lecturer, University of Cambridge, has a 20 year interest in AAT. ... The business of company creation. Spin-outs and start-ups

7 Jan 2015: 20. Linking Cambridge Enterprise to academia. Enterprise Champions. Academics and researchers provide an invaluable link between Cambridge Enterprise and University departments and their networks. ... Total expenditure (18,880) (19,192). Net

6 Jan 2014: in 20 years in the industry,” said Dr David Grainger,. Venture Partner at Index Ventures and Chief Scientific. ... networks and suspension systems, started more than. 20 years ago by Professor Malcolm Smith of the.

3 Oct 2019: Name of inventionBrief description. Case Ref: Mor-2564-11. • EPCs are easily available from small volumes of peripheral blood (20-40 mL in adults) and rapidly expandable in culture. •

16 Jan 2018: Traditionally water testing has taken 10 to 20 hours;requires expensive, heavy equipment and must bedone by highly trained workers, usually off site.WaterScope’s technology is significantly smaller,lighter and ... Income forservices andotherincome 991

21 Apr 2008: 3. 0. 20. 40. 60. 80. 2002/03 2003/04 2004/05 2005/06 2006/07. ... Mentors who typically possess 20 –30 years of relevant industry experience and provide advice directly toindividuals and small companies.

5 Jul 2023: Equity portfolio 20. Contact 21. R E A D M O R E Scan the QR code to view our full Annual Review. ... Our international work encompasses both consultancy and training. On the consultancy side, the pandemic forced the cancellation of a visit to Cambridge

15 Jun 2015: The first two models above have become common in some US universities and typically take the form of 5-20% founding equity stakes with anti-dilution to the end of Series

28 Jan 2019: 20 Cambridge Enterprise Annual Review. Case studyA new vision for saving glaucoma patients’ eyesight. ... Income before returns from equity realisation 13,543 20,104. Equity realisation income to Cambridge Enterprise and University Seed Funds 597 3,679.

3 Jul 2023: 18. 20. 22. 24. Annual Review 2022 | 32 | Annual Review 2022. ... Dr Louise Allen Cambridge University Hospitals NHS Foundation Trust. 20 | Impact Stories Impact Stories | 21.

19 Dec 2011: 25. 118 117143 154. Technology Transfer: Physical Sciences. Shedding a new lightWorldwide approximately 1.6 billion people, more than 20% of the global population, lack access to mains.

18 Aug 2021: Case Ref: Pen-7846-20. Dr Isil Top-MartinezCommercialisation AssociateIsil.top-martinez@enterprise.cam.ac.uk. Brian Moore is Emeritus Professor in the Department of Psychology at the University of Cambridge.

6 Jan 2011: 0. 20. 40. 60. 80. 100. 120. 140. 160. 2009/10. 2008/09. ... Returned to Seed Funds. Margin contribution to group. 20 Annual Review 2010.

26 Mar 2024: 18. 20. 22. 24. Annual Review 2022 | 32 | Annual Review 2022. ... Dr Louise Allen Cambridge University Hospitals NHS Foundation Trust. 20 | Impact Stories Impact Stories | 21.

18 Nov 2021: Case Ref: MOL-7671-20. Sarah Richardson Commercialisation AssociateSarah.Richardson@enterprise.cam.ac.uk. Professor Payne is Chair of Computational Physics at the University of Cambridge.

23 Mar 2009: plot the 20 year course of Plastic Logic and Smart. Holograms, just two of many significant and mature. ... Mentors, typically with 20–30 years of relevant. industry experience, provide advice directly to.

9 Mar 2010: Signed Consultancy Agreements2006/07–2008/09. 100. 60. 20. 2008/09. 10. 30. 50. 70. ... 20 Annual Review 2009. Marketing. Communicating ImpactThe University of Cambridge has a long history of.